CLOSE

Specials

  • March
  • BioTech Startups
  • Genomics Europe
  • Bioanalytical Services Europe
  • Sustainable Technologies
  • BioTech Startup APAC
  • Life Science Packaging
  • Europe
  • APAC
  • Bioanalytical Services APAC
  • Life Science Compliance
  • Life Science Analytics
  • Bioanalytical Services
  • September
  • June
  • Contract Research Organization

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
EUROPE
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Drug Development: The Role of Analytical and Bioanalytical Sciences

Drug Development: The Role of...

An Insight into Pharmaceutical Analytical Testing Services' Market

An Insight into Pharmaceutical...

Why is Drug Discovery and Essential Practice

Why is Drug Discovery and Essential...

PCR Biosystems Launches a Range of IsoFast Bst Polymerase Reagents

PCR Biosystems Launches a Range of...

Bioanalytical Challenges of Antibody Drug Conjugates

Bioanalytical Challenges of Antibody...

What are Regulatory Submissions in Bioanalytics

What are Regulatory Submissions in...

Using Technology to Simplify the Drug Development Journey

Using Technology to Simplify the Drug...

Recent Trends and Developments in Pharmaceutical Industry

Recent Trends and Developments in...

Drug Development: The Role of Analytical and Bioanalytical Sciences

Drug Development: The Role of...

An Insight into Pharmaceutical Analytical Testing Services' Market

An Insight into Pharmaceutical...

Why is Drug Discovery and Essential Practice

Why is Drug Discovery and Essential...

PCR Biosystems Launches a Range of IsoFast Bst Polymerase Reagents

PCR Biosystems Launches a Range of...

Bioanalytical Challenges of Antibody Drug Conjugates

Bioanalytical Challenges of Antibody...

What are Regulatory Submissions in Bioanalytics

What are Regulatory Submissions in...

Using Technology to Simplify the Drug Development Journey

Using Technology to Simplify the Drug...

Recent Trends and Developments in Pharmaceutical Industry

Recent Trends and Developments in...

Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin

By Life Sciences Review | Tuesday, March 23, 2021
Tweet

The resin provides a dependable, flexible, and repeatable Factor H downstream process, overcoming traditional purification methods’ inherent challenges.


FREMONT, CA: B3C newswire Eleva GmbH (Eleva), a manufacturer of superior biologics derived from its patented moss expression system, and Navigo Proteins GmbH (Navigo), a premier protein engineering company and creator of affinity ligands for custom chromatography solutions, announced the successful incorporation of a tailored affinity chromatography resin into the purification process of Eleva’s Complement- Factor. The affinity chromatography resin has been developed using Navigo’s proprietary platform to efficiently purify enzymatically active Factor H from moss cell culture medium.


“We are delighted to be able to work together with a great Eleva team to successfully develop an innovative affinity chromatography solution for the purification of CPV-101. Our custom affinity chromatography technology immediately showed its full potential for efficient production of CPV-101 with excellent purity and yield.


 We are looking forward to continue our support of Eleva by delivering validated resin for production of clinical grade material,” said Florian Settele, Navigos Head of Precision Capturing.


 


The resin provides a dependable, flexible, and repeatable Factor H downstream process, overcoming traditional purification methods’ inherent challenges. The validation of clinical and industrial resin supply to enable the potential production of CPV-101 is still underway.


Sören Boller, Elevas Head of Downstream Process Development, added, “After receiving the affinity chromatography resin for the purification of CPV-101 from Navigo, we performed numerous experiments to challenge the resin. We were amazed to see an excellent purity after only a single purification step. This powerful tool allows for flexible design of a CPV-101 purification strategy, eventually leading to a successful purification of CPV-101. We are looking forward to continuing the successful collaboration with Navigo and are excited to test the affinity resin in larger scale.”


Weekly Brief

loading
Towards a New World Order
> <
  • Life Science Compliance 2021

    Top Vendors

    Current Issue
  • Other 2021

    Top Vendors

    Current Issue

Read Also

Genome Sequencing Technology Becoming More Efficient

Genome Sequencing Technology Becoming More Efficient

Contract Research Organization: Top Benefits

Contract Research Organization: Top Benefits

Genomics: How Can Employing AI Enhance Healthcare?

Genomics: How Can Employing AI Enhance Healthcare?

The Potential of Strategic Partnering with CROs

The Potential of Strategic Partnering with CROs
Advantages of Using Glass Pharmaceutical Packaging

Advantages of Using Glass Pharmaceutical Packaging

How Cloud-Based LIMS Helps CROs

How Cloud-Based LIMS Helps CROs

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

What You Should Know About Biotechnology

What You Should Know About Biotechnology
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/navigo-proteins-and-eleva-announce-successful-development-of-an-affinity-chromatography-resin-nwid-294.html